alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, 
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, Colman Cheng, the Chief Financial Officer and Treasurer of CHINA NUTRIFRUIT GROUP LIMITED (the Company), DOES HEREBY CERTIFY that:

1.

The Companys Quarterly Report on Form 10-Q for the quarter ended
September 30, 2009 (the "Report"), fully complies with the requirements of
Section 13(a) of the Securities Exchange Act of 1934; and

2.

Information contained in the Report fairly presents, in all
material respects, the financial condition and results of operation of the
Company.

IN WITNESS WHEREOF, each of the undersigned has executed this statement this 16th day of November, 2009.

/s/ Colman ChengColman Cheng 
Chief Financial Officer and Treasurer  
(Principal Financial and Accounting Officer)

A signed original of this written statement required by Section 906 has been provided to China Nutrifruit Group Limited and will be retained by China Nutrifruit Group Limited and furnished to the Securities and Exchange Commission or its staff upon
request.

The forgoing certification is being furnished to the Securities and Exchange Commission pursuant to § 18 U.S.C. Section 1350. It is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be
incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

---
II 

112TH CONGRESS 

2D SESSION S. 2672 

To suspend temporarily the rate of duty on 1,1-cyclobutanedicarboxylic acid. 

IN THE SENATE OF THE UNITED STATES 

MAY 7, 2012 

Mr. CASEY introduced the following bill; which was read twice and referred 

to the Committee on Finance 

A BILL 

To suspend temporarily the rate of duty on 1,1- 

cyclobutanedicarboxylic acid. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. 1,1-CYCLOBUTANEDICARBOXYLIC ACID. 

4 (a) IN GENERAL.—Subchapter II of chapter 99 of 

5 the Harmonized Tariff Schedule of the United States is 

6 amended by inserting in numerical sequence the following 

7 new heading: 

‘‘ 9902.01.00 1,1- 

Cyclobutanedicarboxylic 

acid (CAS No. 5445–51–2) 

(provided for in subheading 2917.20.00) ......... Free No change No change On or before 

12/31/2015 ’’. 


rfrederick on DSK6VPTVN1PROD with BILLS
2 

•S 2672 IS

1 (b) EFFECTIVE DATE.—The amendment made by 

2 subsection (a) applies to articles entered, or withdrawn 

3 from warehouse for consumption, on or after the 15th day 

4 after the date of the enactment of this Act. 

Æ 


rfrederick on DSK6VPTVN1PROD with BILLS
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2664 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2664

To extend the temporary suspension of duty on 2,3-dichloronitrobenzene.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 7, 2012

   Mr. Casey introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
To extend the temporary suspension of duty on 2,3-dichloronitrobenzene.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. 2,3-DICHLORONITROBENZENE.

    (a) In General.--Heading 9902.22.20 of the Harmonized Tariff 
Schedule of the United States (relating to 2,3-dichloronitrobenzene) is 
amended by striking the date in the effective period column and 
inserting ``12/31/2015''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
**EXHIBIT 31.1****Chief Executive Officer Certification**I, Paul O. Bower, certify that:1. I havereviewed this Amendment No. 1 to the Annual Report on Form 10-K of Education Realty Trust, Inc.;2. Based on my knowledge, this report does not contain any untrue statement of a material fact oromit to state a material fact necessary to make the statements made, in light of the circumstancesunder which such statements were made, not misleading with respect to the period covered by thisreport.Datedthis 28thday of March, 2008.         /s/ Paul O. Bower   Paul O. Bower, Chief Executive Officer
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No. 03-1147
TERRI BAKER, Plaintiff - Appellant, versus GREYHOUND BUS LINE; RAY ROBINSON, Defendants - Appellees. Appeal from the United States District Court for the District ofMaryland, at Baltimore. J. Frederick Motz, District Judge. (CA02-3239-JFM) Submitted: May 15, 2003 Decided: May 20, 2003 Before LUTTIG and KING, Circuit Judges, and HAMILTON, Senior Circuit Judge. Affirmed by unpublished per curiam opinion. Terri Baker, Appellant Pro Se. Karla Grossenbacher, Emily R. Friedman, SEYFARTH SHAW, Washington, D.C., for Appellees. Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).2 PER CURIAM: Terri Baker appeals the district court’s order denying her suit alleging discrimination based on race and disability. We have reviewed the record and find no reversible error. Accordingly, we affirm on the reasoning of the district court. See Baker v. Greyhound Bus Line , No. CA-02-3239-JFM (D. Md. Jan. 14, 2003). We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

AFFIRMED
Regina MINER-MCFADDEN, Appellant, v. Robert I. MARTIN, Appellee.

Case No. 2D16-4421

District Court of Appeal of Florida, Second District.

Opinion filed December 22, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
# Fourth Court of Appeals

**San Antonio, Texas**

JUDGMENT

No. 04

- 20

- 00106

- CV

SINKIN & BARRETTO, P.L.L.C. and Stephanie Bandoske as Personal Representative of the Estate of Arthur Gregory Augustine, Deceased, Appellants

v.

COHESION PROPERTIES, LTD.

, Appellee

From the 45th Judicial District Court

, Bexar County, Texas

Trial Court No. 2016

- CI

- 00637

Honorable Cathleen M. Stryker , Judge Presiding

BEFORE CHIEF JUSTICE MARTINEZ

, JUSTICE ALVAREZ , AND JUSTICE RIOS

In accordance with this court’s memorandum opinion of this date, the trial court’s denial, by operation of law, of Appellants’ motion to dismiss under the Texas Citizens Participation Act is REVERSED and this case is REMANDED to the trial court for proceedings consistent with this opinion. It is ORDERED that Appellants Sinkin & Barretto, P.L.L.C. and Stephanie Bandoske as Personal Representative of the E state of Arthur Gregory Augustine, Deceased, recover their costs on appeal from Appellee Cohesion Properties, Ltd.

SIGNED April 28, 2021.

_____________________________ Irene Rios, Justice
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTIANS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED FINANCIAL STATEMENTS AS OF 7/31/00 AND IS QUALIFIED IN ITS ENTIRETY
BY REFERENCE TO SUCH 10-QSB.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          JAN-31-2001
<PERIOD-START>                             FEB-01-2000
<PERIOD-END>                               JUL-31-2000
<CASH>                                          38,373
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                38,373
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                  38,373
<CURRENT-LIABILITIES>                          337,620
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         3,407
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                    38,373
<SALES>                                              0
<TOTAL-REVENUES>                                 5,741
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                               157,498
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                (5,741)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (5,741)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (151,757)
<EPS-BASIC>                                      (.05)
<EPS-DILUTED>                                    (.05)


</TABLE>
EXHIBIT 32.1





CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF
2002





In
connection with the annual report of Pharma-Bio Serv, Inc. (the
“Company”) on Form 10-K/A for the fiscal year ended
October 31, 2018 as filed with the Securities and Exchange
Commission on the date hereof (the “report”), the
undersigned, Victor Sanchez, Chief Executive Officer of the
Company, and Pedro J. Lasanta, Chief Financial Officer of the
Company, each certify, pursuant to 18 U.S.C. § 1350, as
adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002,
that to our knowledge:





1.
 The
report fully complies with the requirements of Section 13(a) or
Section 15(d) of the Securities Exchange Act of 1934, as amended;
and


2.
 The information contained in the report fairly
presents, in all material respects, the financial
condition and results of
operation of the Company.








Dated:
February 28, 2019





/s/ Victor Sanchez

/s/ Pedro J. LasantaVictor Sanchez
Chief Executive Officer(principal executive officer)

Pedro J. Lasanta
Chief Financial Officer
(principal financial and accounting officer)








This certification accompanies the Form 10-K/A to which it relates,
is not deemed filed with the Securities and Exchange Commission and
is not to be incorporated by reference to any filing of Pharma-Bio
Serv, Inc. under the Securities Act of 1933, as amended, or the
Securities Exchange Act of 1934, as amended (whether made before or
after the date of the Form 10-K/A), irrespective of any general
incorporation language contained in such filing.
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                           DEC-31-1997
<PERIOD-START>                              JAN-01-1997
<PERIOD-END>                                SEP-30-1997
<CASH>                                           76,391 
<SECURITIES>                                          0 
<RECEIVABLES>                                   485,311 
<ALLOWANCES>                                          0 
<INVENTORY>                                      81,390 
<CURRENT-ASSETS>                                724,675 
<PP&E>                                          119,920 
<DEPRECIATION>                                        0 
<TOTAL-ASSETS>                                  867,175 
<CURRENT-LIABILITIES>                           583,767 
<BONDS>                                         138,334 
<PREFERRED-MANDATORY>                                 0 
<PREFERRED>                                           0 
<COMMON>                                        124,981 
<OTHER-SE>                                       20,093 
<TOTAL-LIABILITY-AND-EQUITY>                    867,175 
<SALES>                                               0 
<TOTAL-REVENUES>                              2,028,279 
<CGS>                                                 0 
<TOTAL-COSTS>                                 1,269,802 
<OTHER-EXPENSES>                                863,993 
<LOSS-PROVISION>                                      0 
<INTEREST-EXPENSE>                               38,512 
<INCOME-PRETAX>                                (143,656)
<INCOME-TAX>                                          0 
<INCOME-CONTINUING>                            (143,656)
<DISCONTINUED>                                        0 
<EXTRAORDINARY>                                       0 
<CHANGES>                                             0 
<NET-INCOME>                                   (143,656)
<EPS-PRIMARY>                                      (.01)
<EPS-DILUTED>                                       .00 
         

</TABLE>
**EXHIBIT
      32.1**





**CERTIFICATION
      PURSUANT TO**


**18
      U.S.C. SECTION 1350,**


**AS
      ADOPTED PURSUANT TO**


**SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002**





In
      connection with the Quarterly Report of Sierra Health Services, Inc. (the
      Company) on Form 10-Q for the period ending June 30, 2007 as filed with the
      Securities and Exchange Commission on the date hereof (the Report), I, Anthony
      M. Marlon, M.D., Chief Executive Officer of the Company, certify, pursuant
      to 18
      U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
      Act of 2002, that:





The
      Report fully complies with the requirements of section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and





The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and results of operations of the Company.








/s/
      Anthony M. Marlon, M.D.


Anthony
      M. Marlon, M.D.


Chief
      Executive Officer


July
      31,
      2007
Brian Jason KONECNY, Appellant, v. STATE of Florida, Appellee.

Case No. 2D16-4847

District Court of Appeal of Florida, Second District.

Opinion filed November 8, 2017.

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
Panel rehearing granted by order filed 4/27/99; opinion filed 10/5/98 was vacated.ON PETITION FOR REHEARING UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No. 98-6037

UNITED STATES OF AMERICA, Plaintiff - Appellee, versus STEPHEN AUSTIN PILLARS, Defendant - Appellant.Appeal from the United States District Court for the Western District of Virginia, at Roanoke. Samuel G. Wilson, Chief District Judge. (CR-92-85-R, CA-96-137-R) Submitted: March 23, 1999 Decided: April 27, 1999 Before MURNAGHAN and LUTTIG, Circuit Judges, and PHILLIPS, Senior Circuit Judge. Affirmed by unpublished per curiam opinion. Stephen Austin Pillars, Appellant Pro Se. Joseph William Hooge Mott, Assistant United States Attorney, Roanoke, Virginia, for Appellee. Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).3 PER CURIAM: Appellant appeals the district court’s order denying his motion filed under 28 U.S.C. § 2255 (1994) (current version at 28 U.S.C.A. § 2255 (West 1994 & Supp. 1998)). We have reviewed the record and the district court’s opinion and find no reversible error. Accordingly, we affirm on the reasoning of the district court. See United States v. Pillars , Nos. CR-92-85-R; CA-96-137-R (W.D. Va. Dec. 17, 1997. See Lindh v. Murphy , 521 U.S. 320, (1997). We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

AFFIRMED
Letter, dated September 28, 2011



 Exhibit 10.2 
 



 
 The Board of Directors of Marshall Edwards Inc. 
 Marshall Edwards, Inc. 
 11975 El Camino Real 

Suite 101 
 San Diego, CA 92130 

Dear Board members: 
 On behalf of Novogen
Limited (“Novogen”), Novogen unconditionally commits to make an equity investment in our subsidiary, Marshall Edwards Inc., in an amount of no less than $2,000,000 on or before June 30, 2012. 

Executed on the 28th day of September 2011: 
  

			
	By:	 	 /s/ William Rueckert

	William Rueckert, Chairman
	Novogen Limited

 140 Wicks Road, North Ryde NSW 2113 

Tel: +6 12 9878 0088 Fax: +61 2 9878 0055
CERTIFICATION PURSUANT TO

18 U.S.C. §1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Annual Report of Cardero Resource Corp. (the Company) on Form 40-F for the year ended October 31, 2006 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Michael W. Kinley, the Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



3.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

4.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Date:  January 29, 2007



/s/ Michael W. Kinley

Michael W. Kinley
  Chief Financial Officer
IN THE SUPREME COURT OF PENNSYLVANIA

WESTERN DISTRICT

DONALD KRIMM AND AUDREY KRIMM, HIS WIFE,

Petitioners

v.

MUNICIPAL AUTHORITY OF WESTMORELAND COUNTY,

Respondent :

:

:

:

:

:

:

:

:

:

:

:

: No. 35 WAL 2017

Petition for Allowance of Appeal from

the Order of the Commonwealth Court

ORDER

PER CURIAM

AND NOW , this 5th day of July, 2017

, the Petition for Allowance of Appeal is

DENIED

.

Petitioner’s motion for post

- submission communication is also GRANTED

.
AMENDMENT TO
      The DynaMotive Energy Systems Corporation 1993 Stock Option Plan

   This amendment to the The DynaMotive Energy Systems Corporation 1993
Stock Option Plan (the "Plan") is made by DynaMotive Energy Systems
Corporation (the "Company") by action of its Board of Directors, effective
as of 28th of December, 2007
      ---------------------

1. Section I of the Plan is amended by adding the following definition at
the end thereof:


   "(m)   ''RESTRICTED STOCK'' means Stock awarded upon the terms and
subject to the restrictions set forth in Section 9."


2. The second paragraph of Section 3 is amended by adding the following at
the end thereof:


   "To the extent that shares of Restricted Stock are forfeited, those
shares of Stock shall again be available for issuance in connection with
future awards under the Plan."


3. The Plan is amended by adding the following new Section 9 at the end
thereof:




























<PAGE>

   "SECTION 9: RESTRICTED STOCK AWARDS.
   The Committee may make grants of Restricted Stock to Participants.
Whenever the Committee deems it appropriate to grant Restricted Stock,
notice shall be given to the Participant stating the number of shares of
Restricted Stock granted and the terms and conditions to which the
Restricted Stock is subject.  Restricted Stock may be awarded by the
Committee in its discretion without cash consideration.


   The Committee shall establish as to each award of Restricted Stock the
following terms and conditions and such additional terms and conditions,
not inconsistent with the terms of the Plan, as the Committee may
determine:


   (a) LAPSE OF RESTRICTIONS.  Each award shall establish the terms and
conditions upon which the restrictions set forth in subsection (b) below
shall lapse.  The terms and conditions may include the passage of time or
the achievement of a performance goal.


   (b) RESTRICTIONS.  No shares of Restricted Stock may be sold, assigned,
transferred, pledged, hypothecated, or otherwise encumbered or disposed of
until the restrictions on the shares as set forth in the Participant's
grant agreement have lapsed or been removed.


   (c) RIGHTS DURING RESTRICTED PERIOD.  Upon the acceptance by a
Participant of an award of Restricted Stock unless the grant agreement
provides otherwise, the Participant shall, subject to the restrictions set
forth in subsection (b) above, have all the rights of a shareholder with
respect to the shares of Restricted Stock, including, but not limited to,
the right to vote the shares of Restricted Stock and the right to receive
all dividends and other distributions paid thereon.  Certificates
representing Restricted Stock shall be held by the Company until the
restrictions lapse and upon request the Participant shall provide the
Company with appropriate stock powers endorsed in blank.


   (d) TAXES.  The provisions of Section 6(d) apply for payment of taxes
in relation to Restricted Stock.  Until arrangements satisfactory to the
Company for payment of taxes have been made, no stock certificate free of
a legend reflecting the restrictions above shall be issued to a
Participant."











<PAGE>
Exhibit 32.2**SECTION 906 CERTIFICATION**               In connection with the quarterly report of Landmark Land Company, Inc. (the “Company”) onForm 10-QSB for the period ending June 30, 2005 as filed with the Securities and ExchangeCommission on the date hereof (the “Report”), I, Joe V. Olree, Vice President and Chief FinancialOfficer of the Company, certify to my knowledge, pursuant to 18 U.S.C. Section 1350, as adoptedpursuant to Section 906 of the Sarbanes-Oxley Act of 2002 that:1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the SecuritiesExchange Act of 1934; and 2. The information contained in the Report fairly presents, in all material respects, thefinancial condition and result of operations of the Company.        August 12, 2005 /s/ JOE V. OLREE   Joe V. Olree        Vice President and Chief Financial Officer
# C_2016305EN.01004201.xml

| 22.8.2016 | EN | Official Journal of the European Union | C 305/42 |
| --- | --- | --- | --- |

22.8.2016

EN

Official Journal of the European Union

C 305/42

---

Action brought on 20 June 2016 — Walfood v EUIPO — Romanov Holding (CHATKA)

(Case T-312/16)

(2016/C 305/57)

Language in which the application was lodged: English

Parties

Parties

Applicant: Walfood SA (Luxembourg, Luxembourg) (represented by: E. Cornu, lawyer)

Applicant:

Defendant: European Union Intellectual Property Office (EUIPO)

Defendant:

Other party to the proceedings before the Board of Appeal: Romanov Holding, SL (La Moraleja, Spain)

Other party to the proceedings before the Board of Appeal:

Details of the proceedings before EUIPO

Details of the proceedings before EUIPO

Applicant of the trade mark at issue: Applicant

Applicant of the trade mark at issue:

Trade mark at issue: International registration designating the European Union in respect of the mark ‘CHATKA’ — International registration designating the European Union No 876 349

Trade mark at issue:

Procedure before EUIPO: Opposition proceedings

Procedure before EUIPO

Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 21 March 2016 in Case R 2870/2014-5

Contested decision

Form of order sought

Form of order sought

The applicant claims that the Court should:

| — | annul the contested decision; |
| --- | --- |

—

annul the contested decision;

| — | order EUIPO to pay the costs. |
| --- | --- |

—

order EUIPO to pay the costs.

Plea in law

Plea in law

| — | Infringement of Article 42(2) and (3) of Regulation No 207/2009. |
| --- | --- |

—

Infringement of Article 42(2) and (3) of Regulation No 207/2009.

---
Ivett BELLO and Xabier Garay, Petitioners, v. DEUTSCHE BANK NATIONAL TRUST COMPANY, as trustee FOR the CERTIFICATEHOLDERS FOR AMERIQUEST MORTGAGE SECURITIES TRUST 2006-M3, Asset Backed Pass-Through Certificates, Series Arsi 2006-M3, Respondent.

Case No. 2D16-209

District Court of Appeal of Florida, Second District.

Opinion filed December 1, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Denied.